gimli
POLYMED stock analysis context
POLY MEDICURE Stock Context for AI Screening
POLY MEDICURE LIMITED is a small-cap stock in Healthcare. This page summarizes key screening signals for POLY MEDICURE, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about POLYMEDPrice
₹1,598.20
1M return
+8.48%
3M return
+27.27%
Market cap
₹16,199.28 cr
PE
46.59
ROE
+16.42%
RSI
58.74
Turnover
₹19.28 cr
Why it can matter in screens
- Momentum: POLYMED is above 50DMA; RSI is 58.74.
- Returns: 1M +8.48%, 3M +27.27%, 6M -14.85%.
- Liquidity: latest turnover is ₹19.28 cr.
- Valuation: PE 46.59, PB n/a, ROE +16.42%, ROCE +20.85%.
- Growth: 3Y sales CAGR +21.75%, 3Y profit CAGR +32.20%.
Try these prompts
- Analyze POLY MEDICURE with valuation, momentum and industry peers
- Compare POLYMED with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare POLYMED with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.